188 related articles for article (PubMed ID: 26226327)
1. Acute Exacerbations of COPD Are Associated With Increased Expression of Heparan Sulfate and Chondroitin Sulfate in BAL.
Papakonstantinou E; Klagas I; Roth M; Tamm M; Stolz D
Chest; 2016 Mar; 149(3):685-95. PubMed ID: 26226327
[TBL] [Abstract][Full Text] [Related]
2. Acute exacerbations of COPD are associated with significant activation of matrix metalloproteinase 9 irrespectively of airway obstruction, emphysema and infection.
Papakonstantinou E; Karakiulakis G; Batzios S; Savic S; Roth M; Tamm M; Stolz D
Respir Res; 2015 Jun; 16(1):78. PubMed ID: 26126526
[TBL] [Abstract][Full Text] [Related]
3. COPD Exacerbations Are Associated With Proinflammatory Degradation of Hyaluronic Acid.
Papakonstantinou E; Roth M; Klagas I; Karakiulakis G; Tamm M; Stolz D
Chest; 2015 Dec; 148(6):1497-1507. PubMed ID: 26226411
[TBL] [Abstract][Full Text] [Related]
4. Bronchoalveolar lavage in COPD: fluid recovery correlates with the degree of emphysema.
Löfdahl JM; Cederlund K; Nathell L; Eklund A; Sköld CM
Eur Respir J; 2005 Feb; 25(2):275-81. PubMed ID: 15684291
[TBL] [Abstract][Full Text] [Related]
5. Relationship between expression of matrix metalloproteinase-9 and adenylyl cyclase-associated protein 1 in chronic obstructive pulmonary disease.
Xie SS; Hu F; Tan M; Duan YX; Song XL; Wang CH
J Int Med Res; 2014 Dec; 42(6):1272-84. PubMed ID: 25332229
[TBL] [Abstract][Full Text] [Related]
6. Relationship between pulmonary matrix metalloproteinases and quantitative CT markers of small airways disease and emphysema in COPD.
Ostridge K; Williams N; Kim V; Bennett M; Harden S; Welch L; Bourne S; Coombs NA; Elkington PT; Staples KJ; Wilkinson TM
Thorax; 2016 Feb; 71(2):126-32. PubMed ID: 26645414
[TBL] [Abstract][Full Text] [Related]
7. Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease.
Molet S; Belleguic C; Lena H; Germain N; Bertrand CP; Shapiro SD; Planquois JM; Delaval P; Lagente V
Inflamm Res; 2005 Jan; 54(1):31-6. PubMed ID: 15723202
[TBL] [Abstract][Full Text] [Related]
8. Distinct emphysema subtypes defined by quantitative CT analysis are associated with specific pulmonary matrix metalloproteinases.
Ostridge K; Williams N; Kim V; Harden S; Bourne S; Coombs NA; Elkington PT; Estepar RS; Washko G; Staples KJ; Wilkinson TM
Respir Res; 2016 Jul; 17(1):92. PubMed ID: 27460105
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress and airway inflammation in severe exacerbations of COPD.
Drost EM; Skwarski KM; Sauleda J; Soler N; Roca J; Agusti A; MacNee W
Thorax; 2005 Apr; 60(4):293-300. PubMed ID: 15790984
[TBL] [Abstract][Full Text] [Related]
10. MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD.
Lowrey GE; Henderson N; Blakey JD; Corne JM; Johnson SR
Respir Med; 2008 Jun; 102(6):845-51. PubMed ID: 18328682
[TBL] [Abstract][Full Text] [Related]
11. Induction of emphysematous lesions in rat lung by beta-D-xyloside, an inhibitor of proteoglycan synthesis.
van Kuppevelt TH; van de Lest CH; Versteeg EM; Dekhuijzen PN; Veerkamp JH
Am J Respir Cell Mol Biol; 1997 Jan; 16(1):75-84. PubMed ID: 8998082
[TBL] [Abstract][Full Text] [Related]
12. Comparative Study of Cytokine Levels in Different Respiratory Samples in Mild-to-Moderate AECOPD Patients.
Hao W; Li M; Zhang Y; Zhang C; Wang P
Lung; 2019 Oct; 197(5):565-572. PubMed ID: 31451927
[TBL] [Abstract][Full Text] [Related]
13. Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma.
Hollander C; Sitkauskiene B; Sakalauskas R; Westin U; Janciauskiene SM
Respir Med; 2007 Sep; 101(9):1947-53. PubMed ID: 17574828
[TBL] [Abstract][Full Text] [Related]
14. Increased deposition of glycosaminoglycans and altered structure of heparan sulfate in idiopathic pulmonary fibrosis.
Westergren-Thorsson G; Hedström U; Nybom A; Tykesson E; Åhrman E; Hornfelt M; Maccarana M; van Kuppevelt TH; Dellgren G; Wildt M; Zhou XH; Eriksson L; Bjermer L; Hallgren O
Int J Biochem Cell Biol; 2017 Feb; 83():27-38. PubMed ID: 27974233
[TBL] [Abstract][Full Text] [Related]
15. Structural features and binding properties of chondroitin sulfates, dermatan sulfate, and heparan sulfate.
Casu B
Semin Thromb Hemost; 1991; 17 Suppl 1():9-14. PubMed ID: 1906198
[No Abstract] [Full Text] [Related]
16. Relationship between the thickness of bronchial wall layers, emphysema score, and markers of remodeling in bronchoalveolar lavage fluid in patients with chronic obstructive pulmonary disease.
Górka K; Soja J; Jakieła B; Plutecka H; Gross-Sondej I; Ćmiel A; Mikrut S; Łoboda P; Andrychiewicz A; Jurek P; Sładek K
Pol Arch Med Wewn; 2016 Jun; 126(6):402-10. PubMed ID: 27362393
[TBL] [Abstract][Full Text] [Related]
17. A comparison of airway and serum matrix metalloproteinase-9 activity among normal subjects, asthmatic patients, and patients with asthmatic mucus hypersecretion.
Ko FW; Diba C; Roth M; McKay K; Johnson PR; Salome C; King GG
Chest; 2005 Jun; 127(6):1919-27. PubMed ID: 15947303
[TBL] [Abstract][Full Text] [Related]
18. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease.
Sethi S; Maloney J; Grove L; Wrona C; Berenson CS
Am J Respir Crit Care Med; 2006 May; 173(9):991-8. PubMed ID: 16474030
[TBL] [Abstract][Full Text] [Related]
19. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease.
Ferhani N; Letuve S; Kozhich A; Thibaudeau O; Grandsaigne M; Maret M; Dombret MC; Sims GP; Kolbeck R; Coyle AJ; Aubier M; Pretolani M
Am J Respir Crit Care Med; 2010 May; 181(9):917-27. PubMed ID: 20133931
[TBL] [Abstract][Full Text] [Related]
20. Increased matrix metalloproteinase (MMPs) levels do not predict disease severity or progression in emphysema.
D'Armiento JM; Goldklang MP; Hardigan AA; Geraghty P; Roth MD; Connett JE; Wise RA; Sciurba FC; Scharf SM; Thankachen J; Islam M; Ghio AJ; Foronjy RF
PLoS One; 2013; 8(2):e56352. PubMed ID: 23441181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
